Carrera Capital Advisors’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.78M Buy
582,144
+324,977
+126% +$1.57M 0.39% 56
2026
Q2
$1.23M Buy
257,167
+5,008
+2% +$22K 0.18% 87
2026
Q1
$1.13M Buy
+252,159
New +$1.1M 0.17% 85

Other funds holding ABUS

Carrera Capital Advisors's ABUS Position: Q3 2026 in Review

Carrera Capital Advisors increased its Arbutus Biopharma (ABUS) stake by 126% in Q3 2026, buying an estimated $1.57M and bringing the position to 582,144 shares worth $2.78M. The position accounts for 0.39% of the portfolio, ranked #56.

Carrera Capital Advisors first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Carrera Capital Advisors held 582,144 shares of Arbutus Biopharma worth $2.78M as of Q3 2026.
  • Carrera Capital Advisors bought 324,977 Arbutus Biopharma shares in Q3 2026, an estimated $1.57M.
  • Arbutus Biopharma made up 0.39% of Carrera Capital Advisors's portfolio in Q3 2026, its #56 holding.
  • Carrera Capital Advisors first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Carrera Capital Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.